A heart pill that halves risk of deathNovember 15th, 2010 - 12:08 pm ICT by IANS
London, Nov 15 (IANS) A heart pill promises to nearly halve the risk of death and save tens of thousands of heart patients every year, researchers say.
Costing just two pounds a day, Eplerenone can revolutionise the treatment of heart complications, one of the biggest killers worldwide. The pill reduces the risk of death by almost 40 percent, and can prevent many people from being hospitalised.
University of Glasgow researchers, in collaboration with doctors from France, US, Sweden and the Netherlands, compared the effects of the drug on almost 3,000 patients for over four years, reports the Daily Mail.
Prof John McMurray, study co-author and cardidologist at the University of Glasgow, said: “This trial will change the way we manage our patients.”
Patients are also far less likely to need long-term care or surgical procedures such as bypass operations, according to the New England Journal of Medicine.
Currently, doctors give patients a pill called Inspra if the standard medications do not work. The daily pill works by reducing the effects of the potentially harmful hormones cortisol and aldosterone.
Heart disease patients are usually prescribed treatments including aspirin and anticoagulants to prevent blood clotting, statins to lower cholesterol and beta blockers for high blood pressure.
Heart disease is caused by a build up of fat in the walls in the coronary arteries, which transport blood to the heart.
This makes the arteries narrower, restricting the flow of blood. This can cause angina, or chest pains, and if the artery is blocked, the patient has a heart attack.
- Aspirin safer than warfarin in preventing stroke: Study - May 03, 2012
- New polypill halves heart disease and stroke risk - May 26, 2011
- Cholesterol busting drugs might be bad for you - Dec 21, 2010
- Daily aspirin cuts bowel cancer death risk - Apr 26, 2012
- Three-pill combo for high BP launched - Nov 22, 2011
- Now, a device to shield cardiac patients from stroke - Mar 28, 2012
- Top 10 major advances in heart disease in 2010 - Dec 22, 2010
- Cardiac rehab 'can improve heart patients' quality of life' - Feb 15, 2011
- Statin can prevent strokes, besides lowering lipids - Jan 05, 2012
- Higher statin doses may not prevent coronary artery disease - Jan 19, 2010
- Aspirin can do more harm than good for healthy people - Aug 31, 2009
- Painkiller weakens anti-clotting action of aspirin - Dec 15, 2009
- Aspirin cuts prostate cancer risk - Oct 27, 2010
- A jab could lower cholesterol by two-thirds - Nov 15, 2011
- Gout drug shows promise against angina - Jun 08, 2010
Tags: beta blockers, bypass operations, chest pains, coronary arteries, daily mail, england journal of medicine, eplerenone, heart complications, heart disease patients, heart patients, high blood pressure, inspra, john mcmurray, journal of medicine, lower cholesterol, new england journal, new england journal of medicine, prof john, transport blood, university of glasgow